NemaLife Launches AI-Powered Platform for Comprehensive Nutritional Bioactive Screening

NemaLife, specializing in nutritional bioactive development and pre-clinical testing, has launched the NemaLife Discovery Flywheel and Efficacy Matrix. This platform uses patented AI-powered organism-on-chip technology, integrating C. elegans, microfluidics, and visual AI to provide empirical evidence of health outcomes from nutritional substances.

The Discovery Flywheel screens bioactives for multiple health benefits, including stress resilience, cognitive health, gut health, metabolic health, muscle performance, and longevity. This high-throughput, cost-effective approach accelerates the development of effective nutritional products by providing rapid, reliable pre-clinical data.

Next
Next

CPRIT Names Kristen Doyle as New CEO, Continuing Legacy of Leadership